Table 6 Classification of DRP (N = 191)
From: Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
Code | Detailed classification | n (%) |
|---|---|---|
P1 | Adverse reactions | 31 (7.6) |
P1.1 | Side-effect suffered (non-allergic) | 27 (6.6) |
P1.2 | Side-effect suffered (allergic) | 4 (1.0) |
P2 | Drug choice problem | 106 (26.1) |
P2.1 | Inappropriate drug (not most appropriate for indication) | 27 (6.7) |
P2.2 | Inappropriate drug form (not most appropriate for indication) | 1 (0.2) |
P2.3 | Inappropriate duplication of therapeutic group or active ingredient | 9 (2.2) |
P2.4 | Contra-indication for drug (incl. Pregnancy/breast feeding) | 15 (3.7) |
P2.5 | No clear indication for drug use | 8 (2.0) |
P2.6 | No drug prescribed but clear indication | 46 (11.3) |
P3 | Dosing problem | 58 (14.3) |
P3.1 | Drug dose too low or dosage regime not frequent enough | 41 (10.1) |
P3.2 | Drug dose too high or dosage regime too frequent | 10 (2.5) |
P3.3 | Duration of treatment too short | 6 (1.5) |
P3.4 | Duration of treatment too long | 1 (0.2) |
P4 | Drug use problem | 58 (14.3) |
P4.1 | Drug not taken/administered at all | 58 (14.3) |
P5 | Interactions | 73 (18.0) |
P5.1 | Potential interaction | 73 (18.0) |
P6 | Others | 80 (19.7) |
P6.1 | Patient dissatisfied with therapy despite taking drug(s) correctly | 23 (5.7) |
P6.2 | Insufficient awareness of health and diseases (possibly leading to future problems) | 48 (11.8) |
P6.3 | Unclear complaints. Further clarification necessary | 2 (0.5) |
P6.4 | Therapy failure (reason unknown) | 7 (1.7) |
Total | *406 (100.0) |